Angel Valve Project

Angel Valve Project is dedicated to the development of sophisticated treatment concepts for mitral valve repair and replacement. With our current lead product, the Mitral Butterfly implant, we focus on the minimally invasive intervention of mitral regurgitation, a condition that affects 2-3% of the world´s population. (learn more about mitral regurgitation)

The Vienna-based (Austria) start-up is a spinoff of the Medical University Vienna, where the inventor Prof. Mohl, an academic surgeon, worked for 40 years in research, patient care, and medical education. He is a serial entrepreneur who started Miracormedicalsystems in 2008, a company treating acute and chronic myocardial jeopardy. He has longstanding experience in surgical repair of the mitral valve.

The development of the Mitral Butterfly was started by Prof. Mohl with the PRIZE program, a prototype developing program of the AWS (Austria Wirtschaftsservice GmbH). During this conceptualizing phase of development, the primary concept was completely reengineered and adapted to medical needs.

Apart from Prof. Mohl, Angel Valve Project´s core team consists of two engineers with multiple years of experience in the medical device industry. The start-up is furthermore supported by a consortium of international partners who are proficient in the fields of intravascular devices, material technology and regulatory affairs. (meet the team and our partners)

Angel Valve Project currently receives funding through the AWS PreSeed grant and participates in international pre-incubation competitions to raise the awareness about our concepts.